Latest
Our lawyers are experts in their fields. Through commentary and analysis, we give you insights into the pressures impacting business today.
VIEW ALLFrom 1982 to 1986, the Claimant was employed by Unilever UK Central Resources Ltd (CRL) to develop technology devices. During that time, he invented two devices to test glucose levels. The rights to these inventions were subsequently sold to Unilever Plc, which filed UK patents for these devices in 1984 with the Claimant named as inventor. Over time Unilever Plc was approached by organisations interested in taking a licence for one of the devices. From these licences (and a subsequent sale of the patent) Unilever Plc received a net benefit of about £24 million.
Under section 39(1) of the Patents Act, inventions made by employees belong to the employer:
Under section 40 of the Patents Act, employees are entitled to compensation in certain circumstances including where the patent is of "outstanding benefit" to the employer.
In 2006, the Claimant applied for compensation on the basis that Unilever had received "outstanding benefit" from his invention. The case was appealed all the way up to the Supreme Court, which ruled that the Claimant should be awarded £2 million.
There are 3 key takeaways from this case:
This case demonstrates the strength of protection offered to employees in the Patents Act. Although it is prudent to include detailed intellectual property clauses in employment contracts (particularly for staff involved in research and development), such clauses don't override the compensation requirement under the Patents Act. Businesses should nevertheless take care to ensure that they have the correct protection in place for all intellectual property generated by staff.
Our lawyers are experts in their fields. Through commentary and analysis, we give you insights into the pressures impacting business today.
VIEW ALL